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In ICU settings, the diagnosis and treatment of acute
myocardial infarction (AMI) are challenging, partly
because cardiac troponin increase occurs frequently.
In the previous issue of Critical Care, Ostermann and
colleagues reported that myocardial infarction (MI),
screened by plasma troponin and electrocardiography
changes, is common and often clinically unrecognized
in the ICU. Although the clinical significance of
underdiagnosed MIs remains unclear, this approach
may help to target and further investigate the at-risk
population for appropriate therapy.patients (nearly 70%) do not have coronary diseases as
assessed by stress echocardiography or post-mortem diag-In the previous issue of Critical Care, Ostermann and col-
leagues [1] studied the impact of serial troponin measure-
ments on the detection and diagnosis of acute myocardial
infarction (AMI) in patients in the ICU. AMI indeed rep-
resents a specific diagnostic and therapeutic challenge in
ICU settings. Its universal definition - rise or fall (or both)
of cardiac biomarkers, preferably cardiac troponin (cTn),
above the 99th percentile of the upper reference limit as-
sociated with clinical, electrical, or imaging symptoms of
ischemia [2] - has limitations in the ICU. Sedation and an-
algesia mask ischemic chest pain, many of the accompany-
ing signs of (MI) such as hypotension and arrhythmias are
often non-specific, and cardiac biomarkers are somewhat
difficult to interpret. In addition, imaging investigations to* Correspondence: k-klouche@chu-montpellier.fr
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2014assess MI are not routinely performed and are initiated
only when the diagnosis is strongly suspected. Neverthe-
less, identifying patients with ischemia and infarction is
important from diagnostic, prognostic, and treatment
perspectives.
Intensivists frequently rely on electrocardiography (ECG)
evidence of myocardial ischemia, but continuous 2- or 12-
lead ECG routine screening remains poorly satisfactory be-
cause of a low sensitivity and lack of specificity compared
with non-ICU patients [3,4]. It may be improved when as-
sociated with knowledge of cTn values [4], but the inci-
dence of raised serum cTn is high in critically ill patients,
varying from 32% to 53% [5]. Interestingly, most of these
nosis [6]. In the prospective observational study by
Ostermann and colleagues [1], 144 consecutive patients
admitted to the ICU for non-cardiac reasons were
screened by recording ECGs and plasma high-sensitivity
cardiac troponin T (hs-cTnT). (Results were blinded for
the medical team caring for the patient if not ordered on
clinical grounds.) Among patients studied, 121 (84%) expe-
rienced at least one plasma hs-cTnT of more than 15 ng/L
and only 7 (6%) had a normal value at admission. After
analyses, they were classified into four groups: (a) definite
MI: cardiac troponin T (cTnT) of at least 15 ng/L and
ECG changes of MI: 20 (14%); (b) possible MI: cTnT of at
least 15 ng/L and ischemic ECG changes: 39 (27%); (c)
troponin rise alone (cTnT of at least 15 ng/L): 62 (43%); or
(d) normal: 23 (14%). More than 40% of patients (59) had
study-identified MIs, but only 12 of these were suspected
by the ICU team, meaning that more than 80% of MIs
were misdiagnosed. However, a similar mortality was ob-
served between clinically recognized and unrecognizedl Ltd. The licensee has exclusive rights to distribute this article, in any medium,
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erly cited.
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sus 7 ICU days and 51 versus 18 hospital days, P = 0.02).
These findings confirm previous reports underlining
that MI, routinely screened by combined ECG changes
and plasma hs-cTnT, is quite common and underdiag-
nosed in ICUs [7]. It is, however, unclear whether know-
ledge of cTn values when interpreting ECGs leads to an
appropriate diagnosis or over-diagnosis of AMI. Indeed,
clinical significance of MI remains questionable since
Ostermann and colleagues [1] did observe a similar mor-
tality whether it was clinically recognized or not.
ICU patients are at high risk for myocardial ischemia
because of older age, increased intrinsic and extrinsic sym-
pathetic stimulation, hypoxia, vasopressor use, and coagu-
lation disorders. However, myocardial necrosis may be
induced by coronary atherothrombosis or by other trig-
gers that cause an imbalance between coronary oxygen
supply and myocardial oxygen demand [8]. The presence
of elevated cTn, in addition to ECG changes, may help to
make a decision to rule in or out MI or to ascertain it as
did Ostermann and colleagues [1]. The recent analytical
methods using high-sensitivity cardiac troponin (hs-cTn)
assays are far more sensitive and improve the diagnosis of
MI but at the price of a reduction in specificity [9].
Thus, several issues regarding the use of hs-cTn in the
ICU should be addressed. First, determination of the 99th
percentile of hs-cTn could be either variable in this spe-
cific population mostly characterized by older age and co-
morbidities. While this value increases in older (more
than 65 years old) patients admitted to the emergency
room [10], it dramatically decreases when, in order to
screen volunteers, questionnaires for comorbidity, glom-
erular filtration rate level, ECG, or cardiac imaging were
added [11]. Therefore, the universal upper reference limit
lacks specificity in the critically ill. Second, the appreci-
ation of rise or fall of cTn levels during a 3- or 6-hour kin-
etic, though still debated, seems to be determinant to rule
in AMI [11,12]. In the ICU, the search for the optimal
delta change should take into account the patient’s specific
conditions such as vasopressor-induced troponin rise [11].
Finally, an increase in cTn is due not only to myocardial
cell necrosis but also to the release of cytosolic troponin
pool from damaged myocytes that could be detected in
plasma with high-sensitivity assay in both reversible and
irreversible myocardial injury. Situations leading to high-
sensitivity troponin level rise (recently reviewed in [12,13])
are particularly frequent in the ICU and include kidney
disease, heart or respiratory failure (or both), sepsis,
pulmonary embolism, stroke, Tako-tsubo, myocarditis,
trauma, cardiopulmonary resuscitation, and tachycardia.
In conclusion, the diagnosis of AMI remains challen-
ging in the ICU, and the use of high-sensitivity troponin
T as a diagnostic tool should be prudent because it may
lead to an overestimation of evidence of ischemia. Toincrease the accuracy for diagnosing MI, one should re-
serve invasive or non-invasive procedures, such as bed-
side echocardiography or coronary angiography, to a
targeted population. The work of Ostermann and col-
leagues [1] provides further information to best identify
this at-risk population. Yet the equivalence in outcomes
between clinically recognized and unrecognized MI may
reflect the challenge of appropriate and timely medical
intervention for MIs. Larger trials will be necessary to
further evaluate the utility of troponin-based clinical al-
gorithms to an improvement in outcomes.
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